Carnitine has been reported as highly efficient in the downregulation of pro-inflammatory cytokines TNF-α and IL-6 in murine models of cancer cachexia [24, 36], liver fibrosis [23] and in blocking TNF-α-induced insulin resistance in skeletal muscle cells [48]. This evidence concerns the gene TNF and Hepatic fibrosis.